Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...
Zacks.com on MSN2d
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?TransMedics Group, Inc. TMDX investors are continuing to encounter losses from the stock of late. Shares of the Andover, MA-based commercial-stage medical technology company providing organ transplant ...
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ:TMDX). Such ...
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
He instructed the Health and Family Welfare Department to stay in touch with the Union Health Ministry to get timely updates about preparedness in the capital. “No need to delay action, bring issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback